{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:16:37Z","timestamp":1790957797525,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejmech.2021.113518","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T11:33:34Z","timestamp":1620905614000},"page":"113518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Discovery and development of 2-aminobenzimidazoles as potent antimalarials"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-7392","authenticated-orcid":false,"given":"Shane M.","family":"Devine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Challis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-3235","authenticated-orcid":false,"given":"Jomo K.","family":"Kigotho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-3198","authenticated-orcid":false,"given":"Ghizal","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7617-9655","authenticated-orcid":false,"given":"Amanda","family":"De Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3694-3989","authenticated-orcid":false,"given":"Christopher A.","family":"MacRaild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky M.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Creek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Scammells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113518_bib1","series-title":"World Malaria Report 2020: 20 Years of Global Progress and Challenges","first-page":"1","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113518_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113518_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113518_bib4","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/AAC.00032-10","article-title":"Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum","volume":"54","author":"Imwong","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113518_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113518_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062906","article-title":"The open access malaria Box: a drug discovery catalyst for neglected diseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113518_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/mmi.12765","article-title":"Diverse chemotypes disrupt ion homeostasis in the malaria parasite","volume":"94","author":"Lehane","year":"2014","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113518_bib8","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1128\/AAC.01226-16","article-title":"Metabolomics-based screening of the malaria box reveals both novel and established mechanisms of action","volume":"60","author":"Creek","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113518_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0169-4758(87)90147-5","article-title":"Spread of chloroquine resistance in Plasmodium falciparum","volume":"3","author":"Payne","year":"1987","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ejmech.2021.113518_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A\u00a0molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113518_bib11","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/acs.jmedchem.9b00761","article-title":"The development process for discovery and clinical advancement of modern antimalarials","volume":"62","author":"Ashton","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib12","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/jm300041e","article-title":"Imidazolopiperazines: lead optimization of the second-generation antimalarial agents","volume":"55","author":"Nagle","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib13","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-020-15440-4","article-title":"Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway","volume":"11","author":"LaMonte","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113518_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113518_bib15","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1021\/jm3001373","article-title":"3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential","volume":"55","author":"Younis","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2021.113518_bib17","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1073\/pnas.1015762108","article-title":"Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria","volume":"108","author":"Charman","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113518_bib18","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1071\/CH13266","article-title":"Development of inhibitors of Plasmodium falciparum apical membrane antigen 1 based on fragment screening","volume":"66","author":"Lim","year":"2013","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/C6MD00495D","article-title":"Antimalarial drug discovery targeting apical membrane antigen 1","volume":"8","author":"Devine","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113518_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jmr.2529","article-title":"Solution NMR characterization of apical membrane antigen 1 and small molecule interactions as a basis for designing new antimalarials","volume":"29","author":"Krishnarjuna","year":"2016","journal-title":"J.\u00a0Mol. Recogn."},{"key":"10.1016\/j.ejmech.2021.113518_bib21","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1021\/jm500535j","article-title":"Aminoazabenzimidazoles, a novel class of orally active antimalarial agents","volume":"57","author":"Hameed","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib22","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1021\/jm500715u","article-title":"N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds","volume":"57","author":"Ramachandran","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/acs.jmedchem.8b01769","article-title":"Structure-activity relationship studies and Plasmodium life cycle profiling identifies pan-active N-Aryl-3-trifluoromethyl pyrido[1,2-a]benzimidazoles which are efficacious in an in\u00a0vivo mouse model of malaria","volume":"62","author":"Mayoka","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib24","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1021\/acsomega.0c00327","article-title":"Lerisetron analogues with antimalarial properties: synthesis, structure\u2013activity relationship studies, and biological assessment","volume":"5","author":"Mueller","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2021.113518_bib25","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1021\/acs.jmedchem.5b00114","article-title":"A\u00a0developability-focused optimization approach allows identification of in\u00a0vivo fast-acting antimalarials: N-[3-[(benzimidazol-2-yl)amino]propyl]amides","volume":"58","author":"Keurulainen","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib26","doi-asserted-by":"crossref","first-page":"10364","DOI":"10.1002\/anie.201204710","article-title":"Catalyst-controlled chemoselective arylation of 2-aminobenzimidazoles","volume":"51","author":"Ueda","year":"2012","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2021.113518_bib27","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1039\/C4RA11183D","article-title":"An efficient D-glucosamine-based copper catalyst for C-X couplings and its application in the synthesis of nilotinib intermediate","volume":"5","author":"Wen","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113518_bib28","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1039\/C4CC05628K","article-title":"Copper-catalyzed sequential N-arylation of C-amino-NH-azoles","volume":"50","author":"Rao","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113518_bib29","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1039\/C6OB01307D","article-title":"Nickel-catalyzed Chan-Lam cross-coupling: chemoselective N-arylation of 2-aminobenzimidazoles","volume":"14","author":"Kumar","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/jm030614p","article-title":"Dopamine D1\/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1\/D5 antagonists","volume":"48","author":"Wu","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib31","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Synopsis of some recent tactical application of bioisosteres in drug design","volume":"54","author":"Meanwell","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib32","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/jo00111a021","article-title":"Hydrogen-bond donor properties of the difluoromethyl group","volume":"60","author":"Erickson","year":"1995","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib33","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jhet.5570270656","article-title":"Synthesis of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-Imidazo[4,5-b]pyridin-2-amine. An aza analog of enviroxime","volume":"27","author":"Kelley","year":"1990","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib34","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1021\/jm800809f","article-title":"Synthesis and structure\u2212activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators of small conductance Ca2+-activated K+ channels","volume":"51","author":"S\u00f8rensen","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/345253a0","article-title":"Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross","volume":"345","author":"Wellems","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113518_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P.\u00a0falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2021.113518_bib37","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1128\/AAC.05667-11","article-title":"Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial Cinchona alkaloids","volume":"56","author":"Griffin","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113518_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","article-title":"Structure and drug resistance of the Plasmodium falciparum transporter PfCRT","volume":"576","author":"Kim","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113518_bib39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113518_bib40","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/s41467-019-10121-3","article-title":"Genomic structure and diversity of Plasmodium falciparum in Southeast Asia reveal recent parasite migration patterns","volume":"10","author":"Shetty","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113518_bib41","doi-asserted-by":"crossref","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","article-title":"(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium","volume":"111","author":"Jim\u00e9nez-D\u00edaz","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113518_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2021.113518_bib43","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1021\/ac9912247","article-title":"A\u00a0high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates","volume":"72","author":"Bevan","year":"2000","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib44","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/jo971176v","article-title":"NMR chemical shifts of common laboratory solvents as trace impurities","volume":"62","author":"Gottlieb","year":"1997","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113518_bib45","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1021\/acs.organomet.7b00432","article-title":"Catalytic addition of alcohols to carbodiimides mediated by benzimidazolin-2-iminato actinide complexes","volume":"36","author":"Liu","year":"2017","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2021.113518_bib46","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1021\/om060494u","article-title":"Synthesis and study of bidentate Benzimidazolylidene\u2212Group 10 metal complexes and related main-chain organometallic polymers","volume":"25","author":"Boydston","year":"2006","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2021.113518_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0091-679X(08)61844-0","article-title":"Cultivation of malaria parasites","volume":"45","author":"Trager","year":"1994","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113518_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4269\/ajtmh.2012.11-0302","article-title":"Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening","volume":"86","author":"Duffy","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:32:05Z","timestamp":1759329125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421003676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":48,"alternative-id":["S0223523421003676"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113518","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and development of 2-aminobenzimidazoles as potent antimalarials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113518"}}